FDA and EU Extend Confidentiality Arrangements

GMP News No. 642

GMP News
1 December 2005
 

FDA and EU Extend Confidentiality Arrangements

 
FDA, EU Commission and EMEA have prolonged the confidentiality arrangements concluded in September 2003 by another 5 years. The arrangements concern both medicinal products for human and for veterinary use.

The arrangements allow FDA and EU/EMEA to exchange information gathered in their respective regulatory development processes. They include the following items:

  • legal and regulatory issues
  • inspection reports (!)
  • marketing authorisation procedures

You can download the original arrangements of September 2003 here. The implementation plan for the arrangements can be downloaded here

Source: http://www.fda.gov/bbs/topics/news/2005/NEW01257.html

Compiled by
Oliver Schmidt
on behalf of ECA
 

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK